These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7490727)

  • 21. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.
    Matsumoto RR; Bowen WD; Tom MA; Vo VN; Truong DD; De Costa BR
    Eur J Pharmacol; 1995 Jul; 280(3):301-10. PubMed ID: 8566098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 1-phenylcycloalkanecarboxylic acid derivatives are potent and selective sigma 1 ligands.
    Calderon SN; Izenwasser S; Heller B; Gutkind JS; Mattson MV; Su TP; Newman AH
    J Med Chem; 1994 Jul; 37(15):2285-91. PubMed ID: 8057277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.
    Carroll FI; Abraham P; Parham K; Bai X; Zhang X; Brine GA; Mascarella SW; Martin BR; May EL; Sauss C
    J Med Chem; 1992 Jul; 35(15):2812-8. PubMed ID: 1322987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist.
    Reddy NL; Hu LY; Cotter RE; Fischer JB; Wong WJ; McBurney RN; Weber E; Holmes DL; Wong ST; Prasad R
    J Med Chem; 1994 Jan; 37(2):260-7. PubMed ID: 8295213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
    Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
    J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
    Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
    J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy.
    Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK
    Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
    Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
    Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
    Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
    de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
    J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel sigma receptor ligands: synthesis and biological profile.
    Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
    J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
    Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
    J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sites.
    Berardi F; Ferorelli S; Colabufo NA; Leopoldo M; Perrone R; Tortorella V
    Bioorg Med Chem; 2001 May; 9(5):1325-35. PubMed ID: 11377189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
    Palmer RB; Upthagrove AL; Nelson WL
    J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands.
    Wu ZW; Song SY; Li L; Lu HL; Lieberman B; Huang YS; Mach RH
    Bioorg Med Chem; 2015 Apr; 23(7):1463-71. PubMed ID: 25752422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro evaluation of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: high-affinity ligands for the N,N'-di-o-tolylguanidine-labeled sigma binding site.
    Mewshaw RE; Sherrill RG; Mathew RM; Kaiser C; Bailey MA; Karbon EW
    J Med Chem; 1993 Feb; 36(3):343-52. PubMed ID: 8426363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity.
    Holl R; Schepmann D; Fröhlich R; Grünert R; Bednarski PJ; Wünsch B
    J Med Chem; 2009 Apr; 52(7):2126-37. PubMed ID: 19243173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.